AEOLUS PHARMACEUTICALS, INC. company info

CIK 1261734
IRS Number 561953785
State of incorporation DE
Business address 26361 CROWN VALLEY PARKWAY, SUITE 150
None
MISSION VIEJO
CA
92691
Mail address 26361 CROWN VALLEY PARKWAY, SUITE 150
None
MISSION VIEJO
CA
92691

Short summary

AEOLUS PHARMACEUTICALS, INC. is a California company, with head office located at 26361 Crown Valley Parkway, Suite 150 Mission Viejo, California 92691. In 2016 the company owned a total of 794.00 thousand USD worth of assets, including 762.00 thousand USD worth of current assets. 2013 was the year when the company amassed the most assets.

AEOLUS PHARMACEUTICALS, INC. Income Statement

Name [in Millions USD]200820092010201120122013201420152016Trends
Revenue, Net 4.827.293.939.633.11
Research and development 0.711.695.066.473.366.973.512.88
Operating Income (Loss) -2.00-3.64-3.90-2.37-2.70-0.08-2.63-3.27
Interest expense -0.440.880.02000.000.29
Income Tax Expense (Benefit) 0.000.000.000.000.000.00
Net income -2.30-25.870.301.70-3.21-0.08-2.63-3.56

AEOLUS PHARMACEUTICALS, INC. Balance Sheet

Name [in Millions USD]200820092010201120122013201420152016Trends
Cash and cash equivalents 0.400.460.880.212.731.270.423.760.40
Accounts Receivable, Net, Current 0.472.370.342.720.660.740.31
Total assets 1.462.664.094.891.214.870.79
Current assets 1.432.634.064.861.174.840.76
Total current liabilities 0.563.243.003.251.490.690.59
Total liabilities 22.8215.953.003.251.490.690.59
Common Stock, Value, Issued 0.610.631.351.351.361.521.52
Retained Earnings (Accumulated Deficit) -180.26-173.61-183.26-183.48-186.20-189.17-193.26

AEOLUS PHARMACEUTICALS, INC. Cash Flow

Name [in Millions USD]200820092010201120122013201420152016Trends
Net income -2.30-25.870.301.70-3.21-0.08-2.63-3.56
Depreciation 00.000.010.010.010
Accounts receivable 00-1.680.80-0.411.190.03-0.84
Deferred revenue 0.58-0.24-0.42-0.02
Net Cash Provided by (Used in) Operating Activities -1.92-2.45-3.10-0.88-2.970.32-2.44-3.11
Payments to Acquire Property, Plant, and Equipment 0-0.010
Net Cash Provided by (Used in) Investing Activities 0.75-0.01000
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.030.41
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.030.41
Proceeds from Issuance of Common Stock 1.504.3010.663.62002.01
Net Cash Provided by (Used in) Financing Activities 1.424.161.270.643.560.331.026.17
Cash and Cash Equivalents, Period Increase (Decrease) 0.251.71-1.84-0.240.590.65-1.423.06